Cell Therapeutics, Inc. (NASDAQ:CTIC) surged 1.84% to $0.382. Cell
Therapeutics, Inc. develops, acquires and commercializes treatments for cancer.
It focuses on building a biopharmaceutical company with a diversified portfolio
of oncology drugs. Its research, development, acquisition and in-licensing
activities concentrate on identifying and developing less toxic ways to treat
cancer. Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) slid 0.12% to $12.68. The
52-week range of the stock is $9.51-$24.21. Amylin Pharmaceuticals, Inc.
(Amylin) is a biopharmaceutical company engaged in discovery, development and
commercialization of medicines. The Company is marketing two first-in-class
medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN
(pramlintide acetate) injection. PharmAthene, Inc. (AMEX:PIP) is up 2.82% to
$3.65. The 52-week range of the stock is $1.13-$4.96. The stock is up more than
85% year-to-date. PharmAthene, Inc. is a biodefense company engaged in the
development and commercialization of medical countermeasures against biological
and chemical weapons.
Gold, Mining, silver, index, prices, today, oil, crude, dow jones, nasdaq, s&p 500, TSX, barrick gold, toromocho, CUP, goog, msft, aapl, finance, yahoo, bing, google,currency converter, currency, rates, currency tool, currency trading, currency transfers, foreign exchange, conversion, , live currency rates, mid-market, obsolete, precious metals, rate calculations, save money, save time, special units, tips, trade currency, up to the minute, world currency, xe trade, currency symbols
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment